These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 195348)

  • 21. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases.
    Manoharan A; Catovsky D; Clein P; Traub NE; Costello C; O'Brien M; Boralessa H; Galton DA
    Br J Haematol; 1981 May; 48(1):111-6. PubMed ID: 6941808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metamorphosis of chronic myeloproliferative diseases].
    Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
    [No Abstract]   [Full Text] [Related]  

  • 25. Abnormalities of chromosome 1 in myeloproliferative disorders.
    Rowley JD
    Cancer; 1975 Nov; 36(5):1748-57. PubMed ID: 1192363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma of the breast, chronic lymphocytic leukemia, macroglobulinemia, eosinophilic chloroma and myelosclerosis--a unique association.
    Benvenisti DS; DeBellis RH
    Cancer; 1969 May; 23(5):1204-9. PubMed ID: 4976031
    [No Abstract]   [Full Text] [Related]  

  • 27. Myeloproliferative Neoplasms.
    Spivak JL
    N Engl J Med; 2017 Jun; 376(22):2168-2181. PubMed ID: 28564565
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship of erythromonocytic leukemia to other myeloproliferative disorders.
    Shaw MT; Bottomley SS; Bottomley RH; Hussein KK
    Am J Med; 1973 Oct; 55(3):542-8. PubMed ID: 4355172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukaemia complicating a breast cancer after mastectomy and radiotherapy.
    Gardais J
    Scand J Haematol; 1976 May; 16(5):353-6. PubMed ID: 1065954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous occurrence of breast carcinoma and acute myeloid leukemia: case report and review of the literature.
    Mishra PP; Mahapatra M; Choudhry VP; Saxena R; Pati H; Dixit A; Anupama R; Bhattacharya J; Chatterjee T; Dutta P
    Ann Hematol; 2004 Aug; 83(8):541-3. PubMed ID: 14963697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.
    Cattaneo D; Gianelli U; Bianchi P; Cortelezzi A; Iurlo A
    Eur J Intern Med; 2018 Jun; 52():e25-e26. PubMed ID: 29567096
    [No Abstract]   [Full Text] [Related]  

  • 37. An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?
    Langabeer SE
    Eur J Intern Med; 2018 Jun; 52():e37-e38. PubMed ID: 29622375
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission.
    Chabannon C; Bost M; Hollard D
    Leukemia; 1994 Jul; 8(7):1243-4. PubMed ID: 8035619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myeloid leukemia with megakaryocytic predominance and malignant megakaryocyte proliferation. Apropos of 3 cases].
    Nigro M; Ascari E; Compagnoni A; Menestrina F
    Ann Anat Pathol (Paris); 1979; 24(2):171-84. PubMed ID: 294156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.